ATE517874T1 - Pyrimidinone als modulatoren von caseinkinase ii (ck2) - Google Patents

Pyrimidinone als modulatoren von caseinkinase ii (ck2)

Info

Publication number
ATE517874T1
ATE517874T1 AT06826578T AT06826578T ATE517874T1 AT E517874 T1 ATE517874 T1 AT E517874T1 AT 06826578 T AT06826578 T AT 06826578T AT 06826578 T AT06826578 T AT 06826578T AT E517874 T1 ATE517874 T1 AT E517874T1
Authority
AT
Austria
Prior art keywords
caseinkinase
pyrimidinones
modulators
formula
methods
Prior art date
Application number
AT06826578T
Other languages
English (en)
Inventor
Kenneth D Rice
Neel Kumar Anand
Arlyn Arcalas
Charles M Blazey
Joerg Bussenius
Wai Ki Vicky Chan
Hongwang Du
Sergey Epshteyn
Mohamed Abdulkader Ibrahim
Patrick Kearney
Abigail R Kennedy
Moon Hwan Kim
Jean-Claire Limun Manalo
Csaba J Peto
Tsze H Tsang
Amy Lew Tsuhako
Peiwen Zhou
Elena Koltun
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Application granted granted Critical
Publication of ATE517874T1 publication Critical patent/ATE517874T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06826578T 2005-10-21 2006-10-23 Pyrimidinone als modulatoren von caseinkinase ii (ck2) ATE517874T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72934805P 2005-10-21 2005-10-21
PCT/US2006/041505 WO2007048065A2 (en) 2005-10-21 2006-10-23 Pyrimidinones as casein kinase ii (ck2) modulators

Publications (1)

Publication Number Publication Date
ATE517874T1 true ATE517874T1 (de) 2011-08-15

Family

ID=37903550

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06826579T ATE524476T1 (de) 2005-10-21 2006-10-23 Pyrazolopyrimidine als modulatoren von caseinkinase ii (ck2)
AT06826578T ATE517874T1 (de) 2005-10-21 2006-10-23 Pyrimidinone als modulatoren von caseinkinase ii (ck2)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06826579T ATE524476T1 (de) 2005-10-21 2006-10-23 Pyrazolopyrimidine als modulatoren von caseinkinase ii (ck2)

Country Status (7)

Country Link
US (2) US8372851B2 (de)
EP (2) EP1948617B1 (de)
JP (2) JP5376950B2 (de)
AT (2) ATE524476T1 (de)
AU (2) AU2006304875B2 (de)
CA (2) CA2626789A1 (de)
WO (3) WO2007048065A2 (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1928454E (pt) 2005-05-10 2014-12-04 Intermune Inc Derivativos da piridona para modulação do sistema de proteína quinase ativada pelo stress
RU2008145225A (ru) 2006-04-19 2010-05-27 Новартис АГ (CH) Соединения индазола и способы ингибирования cd7
DE102006039255A1 (de) * 2006-08-17 2008-02-21 Bayer Cropscience Ag Insektizide heterocyclische Carbonsäurederivate
KR20100017359A (ko) * 2007-04-25 2010-02-16 엑셀리시스, 인코포레이티드 카제인 키나제 ⅱ （ｃｋ２）조절제로서의 피리미디논
CN102317266A (zh) * 2007-04-25 2012-01-11 埃克塞利希斯股份有限公司 作为pim调节剂的6-苯基嘧啶酮类
ES2369596T3 (es) * 2007-05-04 2011-12-02 Astrazeneca Ab Derivados de amino-tiazolil-pirimidina y su uso para el tratamiento del cáncer.
SI2300013T1 (en) 2008-05-21 2018-03-30 Adriad Pharmacaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
US9273077B2 (en) 2008-05-21 2016-03-01 Ariad Pharmaceuticals, Inc. Phosphorus derivatives as kinase inhibitors
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン， インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
US8338439B2 (en) * 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
CA2986640C (en) 2008-06-27 2019-03-26 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
US11351168B1 (en) 2008-06-27 2022-06-07 Celgene Car Llc 2,4-disubstituted pyrimidines useful as kinase inhibitors
RS53350B (en) 2008-09-22 2014-10-31 Array Biopharma, Inc. SUBSTITUTED COMPOUNDS OF IMIDASO [1,2-B] PYRIDASINE AS INK KINASE INHIBITORS
TWI577680B (zh) 2008-10-22 2017-04-11 亞雷生物製藥股份有限公司 作為ＴＲＫ激酶抑制劑之經取代吡唑并〔１，５－ａ〕嘧啶化合物
CN102271515B (zh) 2008-10-31 2014-07-02 健泰科生物技术公司 吡唑并嘧啶jak抑制剂化合物和方法
US8252057B2 (en) 2009-01-30 2012-08-28 Ethicon Endo-Surgery, Inc. Surgical access device
WO2010129053A2 (en) 2009-05-05 2010-11-11 Dana Farber Cancer Institute Egfr inhibitors and methods of treating disorders
UA110324C2 (en) 2009-07-02 2015-12-25 Genentech Inc Jak inhibitory compounds based on pyrazolo pyrimidine
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
BR112012005550A2 (pt) * 2009-09-11 2015-09-08 Cylene Pharmaceuticals Inc lactamas heterociclo-substituídas farmaceuticamente úteis
PL2493876T3 (pl) * 2009-10-28 2014-06-30 Pfizer Pochodne imidazolu jako inhibitory kinazy kazeinowej
ES2534335T3 (es) 2010-05-20 2015-04-21 Array Biopharma, Inc. Compuestos macrocíclicos como inhibidores de la Trk cinasa
BR112013003388A2 (pt) 2010-08-10 2016-07-12 Celgene Avilomics Res Inc sal de besilato de um inibidor de btk
MX2013004894A (es) 2010-11-01 2013-10-17 Celgene Avilomics Res Inc Compuestos heterociclicos y usos de los mismos.
US9238629B2 (en) 2010-11-01 2016-01-19 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
EP2637502B1 (de) 2010-11-10 2018-01-10 Celgene CAR LLC Mutanten-selektive egfr-hemmer und verwendungen davon
ES2912284T3 (es) 2010-12-08 2022-05-25 Us Health Pirazolopirimidinas sustituidas como activadoras de la glucocerebrosidasa
WO2012149157A2 (en) 2011-04-26 2012-11-01 Bioenergenix Heterocyclic compounds for the inhibition of pask
EP2704572B1 (de) 2011-05-04 2015-12-30 Ariad Pharmaceuticals, Inc. Verfahren zur hemmung der zellproliferation bei efgr-vermitteltem krebs
JP2014517079A (ja) 2011-06-22 2014-07-17 バーテックス ファーマシューティカルズ インコーポレイテッド Ａｔｒキナーゼ阻害剤として有用な化合物
KR20140077963A (ko) 2011-10-20 2014-06-24 글락소스미스클라인 엘엘씨 시르투인 조절제로서의 치환된 비시클릭 아자-헤테로사이클 및 유사체
EP2770830A4 (de) 2011-10-28 2015-05-27 Celgene Avilomics Res Inc Verfahren zur behandlung einer bruton-tyrosinkinase-erkrankung oder -störung
CN102503945A (zh) * 2011-11-28 2012-06-20 华东理工大学 能够抑制表皮生长因子受体的化合物及其应用
CN102408380B (zh) * 2011-12-22 2014-04-16 浙江大学 5-氨基嘧啶硫酮类化合物及其制备方法
US9108927B2 (en) 2012-03-15 2015-08-18 Celgene Avilomics Research, Inc. Salts of an epidermal growth factor receptor kinase inhibitor
CA2866852C (en) 2012-03-15 2020-12-29 Celgene Avilomics Research, Inc. Solid forms of an epidermal growth factor receptor kinase inhibitor
US20150166591A1 (en) 2012-05-05 2015-06-18 Ariad Pharmaceuticals, Inc. Methods and compositions for raf kinase mediated diseases
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2014066795A1 (en) 2012-10-25 2014-05-01 Bioenergenix Heterocyclic compounds for the inhibition of pask
US9278973B2 (en) 2012-10-25 2016-03-08 Bioenergenix Llc Heterocyclic compounds for the inhibition of PASK
CA2892608C (en) 2012-12-07 2021-10-19 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
WO2014100748A1 (en) 2012-12-21 2014-06-26 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
JP6437452B2 (ja) 2013-01-14 2018-12-12 インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ Ｐｉｍキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物
MX2015009057A (es) 2013-01-15 2015-10-05 Incyte Corp Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de cinasa pim.
MX2015009952A (es) 2013-02-08 2015-10-05 Celgene Avilomics Res Inc Inhibidores de cinasas reguladas por señales extracelulares (erk) y sus usos.
US9663519B2 (en) 2013-03-15 2017-05-30 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
WO2014143242A1 (en) 2013-03-15 2014-09-18 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
EP2970289A1 (de) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Inc. Als atr-kinaseinhibitoren nützliche verbindungen
US9611283B1 (en) 2013-04-10 2017-04-04 Ariad Pharmaceuticals, Inc. Methods for inhibiting cell proliferation in ALK-driven cancers
TW201605866A (zh) 2013-08-23 2016-02-16 英塞特公司 可用作ｐｉｍ激酶抑制劑之呋喃并－及噻吩并－吡啶甲醯胺化合物
US9492471B2 (en) 2013-08-27 2016-11-15 Celgene Avilomics Research, Inc. Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
CN103483273B (zh) * 2013-09-12 2015-11-25 浙江工业大学 6-甲基-5-氟-2,4-嘧啶二胺类化合物及其制备与应用
SG10201804791UA (en) 2013-12-06 2018-07-30 Vertex Pharma 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
US9415049B2 (en) 2013-12-20 2016-08-16 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
CA2943363A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
UA121658C2 (uk) 2014-05-23 2020-07-10 Ф. Хоффманн-Ля Рош Аг Сполуки 5-хлордифторметоксифенілпіразолопіримідину як інгібітори янус-кінази
PT3152212T (pt) 2014-06-05 2020-03-13 Vertex Pharma Derivados radiomarcados de um composto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útil como inibidor de atr quinase, preparação do dito composto e diferentes formas sólidas do mesmo
KR20170016498A (ko) 2014-06-17 2017-02-13 버텍스 파마슈티칼스 인코포레이티드 Chk1 및 atr 저해제의 병용물을 사용하는 암의 치료 방법
CN104119319B (zh) * 2014-06-27 2016-03-16 郑州大学 含1,2,3-三氮唑和脲结构单元的嘧啶衍生物及其制备方法和用途
US9822124B2 (en) 2014-07-14 2017-11-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
US10005760B2 (en) 2014-08-13 2018-06-26 Celgene Car Llc Forms and compositions of an ERK inhibitor
JP6734860B2 (ja) 2014-11-06 2020-08-05 リソソーマル・セラピューティクス・インコーポレイテッドＬｙｓｏｓｏｍａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 置換ピラゾロ［１，５−ａ］ピリミジンおよび医療疾患の治療におけるその使用
ES2958391T3 (es) 2014-11-06 2024-02-08 Bial R&D Invest S A Imidazo[1,5-a]pirimidinas sustituidas y su uso en el tratamiento de trastornos médicos
US20180185368A1 (en) 2014-11-06 2018-07-05 Lysosomal Therapeutics Inc. Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
FI3699181T3 (fi) 2014-11-16 2023-03-28 Array Biopharma Inc Kiteinen muoto (s)-n-(5-((r)-2-(2,5-diluorifenyyli)-pyrrolidin-1-yyli)-pyratsolo[1,5-a]pyrimidin-3-yyli)-3-hydroksipyrrolidiini-1-karboksamidivetyysulfaatista
TWI696617B (zh) 2015-04-28 2020-06-21 大陸商上海復尚慧創醫藥研究有限公司 特定蛋白質激酶抑制劑
US9540347B2 (en) 2015-05-29 2017-01-10 Incyte Corporation Pyridineamine compounds useful as Pim kinase inhibitors
AR105967A1 (es) 2015-09-09 2017-11-29 Incyte Corp Sales de un inhibidor de pim quinasa
JP7187308B2 (ja) 2015-09-30 2022-12-12 バーテックス ファーマシューティカルズ インコーポレイテッド Ｄｎａ損傷剤とａｔｒ阻害剤との組み合わせを使用する、がんを処置するための方法
WO2017059251A1 (en) 2015-10-02 2017-04-06 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
LU92852B1 (en) * 2015-10-20 2017-05-02 Athanasios Spathis NURR1:RXR activating compounds for simultaneous treatment of symptoms and pathology of Parkinsons disease
MX2018005087A (es) 2015-10-26 2019-05-16 Loxo Oncology Inc Mutaciones puntuales en cáncer resistente a trk y métodos relacionados con las mismas.
US10045991B2 (en) 2016-04-04 2018-08-14 Loxo Oncology, Inc. Methods of treating pediatric cancers
JP7061602B2 (ja) 2016-04-04 2022-04-28 ロクソ オンコロジー， インコーポレイテッド （Ｓ）－Ｎ－（５－（（Ｒ）－２－（２，５－ジフルオロフェニル）－ピロリジン－１－イル）－ピラゾロ［１，５－ａ］ピリミジン－３－イル）－３－ヒドロキシピロリジン－１－カルボキサミドの液体製剤
EP3440083A4 (de) 2016-04-06 2019-09-18 Lysosomal Therapeutics Inc. Imidazo[1,5-a]pyrimidinyl-carboxamid-verbindungen und deren verwendung in der behandlung von medizinischen störungen
US11124516B2 (en) 2016-04-06 2021-09-21 BIAL-BioTech Investments, Inc. Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
AU2017246455B2 (en) * 2016-04-06 2021-09-30 Bial - R&D Investments, S.A. Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
WO2017192931A1 (en) 2016-05-05 2017-11-09 Lysosomal Therapeutics Inc. SUBSTITUTED IMDAZO[1,2-α]PYRIDINES, SUBSTITUTED IMIDAZO[1,2-α]PYRAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
SG11201809693SA (en) 2016-05-05 2018-11-29 Lysosomal Therapeutics Inc SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
DK3458456T3 (da) 2016-05-18 2020-12-14 Array Biopharma Inc Fremstilling af (s)-n-(5-((r)-2-(2,5-difluorphenyl)pyrrolidin-1-yl)pyrazol[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamid
EP3484864A1 (de) * 2016-07-13 2019-05-22 Centre National de la Recherche Scientifique - CNRS Pyrimidinonderivate und verwendungen davon zur neutralisierung der biologischen aktivität der chemokine
JOP20190092A1 (ar) 2016-10-26 2019-04-25 Array Biopharma Inc عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
CN107311936A (zh) * 2017-02-24 2017-11-03 陕西科技大学 一种具有抗肿瘤活性的甘草查尔酮a与苯乙双胍环合衍生物及其合成方法
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
AU2018274577A1 (en) 2017-05-22 2019-10-10 F. Hoffmann-La Roche Ag Therapeutic compounds and compositions, and methods of use thereof
CN108976172B (zh) * 2017-05-31 2021-12-07 华东师范大学 一类4-嘧啶二胺类小分子有机化合物及其衍生物及其应用
US11242334B2 (en) 2017-08-22 2022-02-08 Js Innopharm (Shanghai) Ltd. Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
AR113922A1 (es) 2017-12-08 2020-07-01 Incyte Corp Terapia de combinación de dosis baja para el tratamiento de neoplasias mieloproliferativas
JP7394074B2 (ja) * 2018-05-31 2023-12-07 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト 治療用化合物
WO2021108483A1 (en) * 2019-11-27 2021-06-03 Genentech, Inc. Therapeutic compounds
CN111559985A (zh) * 2020-05-13 2020-08-21 河南科技大学第一附属医院 具有杀菌作用的噁唑酮类化合物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129020C (de) * 1964-12-15
DD109170A1 (de) * 1974-01-24 1974-10-20
GB8308290D0 (en) * 1983-03-25 1983-05-05 Fujisawa Pharmaceutical Co Pyrimidinone derivatives
JPH06298752A (ja) * 1993-04-16 1994-10-25 Banyu Pharmaceut Co Ltd 抗腫瘍性物質ｂｅ−２６６６８及びその製造法
GB2281295A (en) 1993-08-26 1995-03-01 Zeneca Ltd (2-Fluoroethyl) thio-substituted pyrimidines as nematicides
AU777869B2 (en) * 1999-09-24 2004-11-04 Shire Canada Inc. Method for the treatment or prevention of viral infection using nucleoside analogues
ATE505462T1 (de) 2002-07-22 2011-04-15 Orchid Res Lab Ltd Neue biologischaktive molekü le
DK1663242T3 (da) 2003-08-07 2011-08-01 Rigel Pharmaceuticals Inc 2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
BRPI0417498A (pt) * 2003-12-09 2007-05-29 Us Gov Health & Human Serv método para suprimir uma resposta imune em um indivìduo; método de inibição da proliferação de um célula; método de tratamento de um distúrbio proliferativo em um indivìduo; método para selecionar um agente imunossupressor ou anti-proliferativo; composição farmacêutica e estente vascular
US7402672B2 (en) * 2003-12-11 2008-07-22 Aventis Pharmaceuticals Inc. Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
EP1718297A4 (de) * 2004-01-09 2009-09-02 Smithkline Beecham Corp Neue chemische verbindungen
MXPA06014809A (es) * 2004-06-21 2007-02-12 Hoffmann La Roche Derivados de pirazol-pirimidina.

Also Published As

Publication number Publication date
CA2626789A1 (en) 2007-04-26
WO2007048065A2 (en) 2007-04-26
AU2006304874B8 (en) 2013-07-04
AU2006304875B2 (en) 2013-01-17
CA2626742A1 (en) 2007-04-26
JP5376950B2 (ja) 2013-12-25
WO2007048064A2 (en) 2007-04-26
EP1948663B1 (de) 2011-09-14
EP1948617B1 (de) 2011-07-27
US20090215803A1 (en) 2009-08-27
WO2007048065A3 (en) 2007-06-28
AU2006304874B2 (en) 2013-03-07
JP2009512693A (ja) 2009-03-26
AU2006304875A1 (en) 2007-04-26
AU2006304874A8 (en) 2013-07-04
WO2007048066A2 (en) 2007-04-26
WO2007048064A3 (en) 2007-06-21
EP1948617A2 (de) 2008-07-30
US8101625B2 (en) 2012-01-24
US20100130488A1 (en) 2010-05-27
JP2009512692A (ja) 2009-03-26
AU2006304874A1 (en) 2007-04-26
EP1948663A2 (de) 2008-07-30
ATE524476T1 (de) 2011-09-15
JP5119157B2 (ja) 2013-01-16
US8372851B2 (en) 2013-02-12
WO2007048066A3 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
ATE517874T1 (de) Pyrimidinone als modulatoren von caseinkinase ii (ck2)
EA201070519A1 (ru) Соединения тропана
ATE376833T1 (de) Chinazolinon-derivate als vanilloid-antagonisten
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
DE602005023015D1 (de) Indolderivate als viruzide
PA8649401A1 (es) Analogos de anilino-pirimidina
EA201070786A1 (ru) Бензофуропиримидиноны
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
EA200701840A1 (ru) N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
EA200700699A1 (ru) Ингибиторы взаимодействия между mdm2 и p53
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
HK1133012A1 (en) Pyrimidinones as casein kinase ii (ck2) modulators
MX2007003913A (es) Alquil-piridinas como inhibidores de 11 beta para diabetes.
ATE445593T1 (de) Acetylenderivate
ATE359791T1 (de) Pyrimidin-2,4-dion-derivate als matrix- metalloproteinase-hemmer
ATE478054T1 (de) Benzimidazolderivate
EA200901504A1 (ru) Производные пиразолона, как ингибиторы pde4
UY29141A1 (es) Inhibidores de la adenilato ciclasa soluble
EA200701813A1 (ru) Новые амидозамещенные 6-фенилфенантридины
ATE550326T1 (de) Als modulatoren von hdl einsetzbare verbindungen
CR8955A (es) Hexadecasacaridos biotinilados, su preparacion y su utilizacion
EA200702590A1 (ru) Ингибиторы растворимой аденилатциклазы
SE0300987D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
ATE348803T1 (de) Tryptase-inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties